- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies
Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
47
Companies with a Value score of at least 3, ordered by Value score
47 companies
Curaleaf Holdings
Market Cap: CA$847.1m
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$1.12
7D
9.8%
1Y
-83.4%
Planet 13 Holdings
Market Cap: CA$110.6m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.34
7D
13.3%
1Y
-62.6%
Jushi Holdings
Market Cap: CA$57.6m
A vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States.
JUSH
CA$0.40
7D
11.1%
1Y
-56.5%
MariMed
Market Cap: CA$29.8m
Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.
MRMD
CA$0.11
7D
-4.3%
1Y
-68.1%
Green Thumb Industries
Market Cap: CA$1.7b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$7.02
7D
-2.6%
1Y
-59.1%
Ayr Wellness
Market Cap: CA$22.8m
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.
AYR.A
CA$0.20
7D
14.7%
1Y
-93.9%
Tilray Brands
Market Cap: CA$485.9m
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
TLRY
CA$0.68
7D
-16.0%
1Y
-72.5%
Trulieve Cannabis
Market Cap: CA$890.1m
Operates as a cannabis retailer.
TRUL
CA$4.66
7D
1.3%
1Y
-69.2%
Verano Holdings
Market Cap: CA$265.6m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$0.74
7D
5.7%
1Y
-89.0%
Medexus Pharmaceuticals
Market Cap: CA$68.4m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.12
7D
-2.3%
1Y
35.9%
TerrAscend
Market Cap: CA$133.3m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.38
7D
-21.9%
1Y
-84.9%
Pfizer
Market Cap: CA$124.3b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
CA$10.07
7D
-3.7%
1Y
-17.0%
Cresco Labs
Market Cap: CA$382.0m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.
CL
CA$0.86
7D
8.9%
1Y
-68.1%
Decibel Cannabis
Market Cap: CA$31.7m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.055
7D
0%
1Y
-60.7%
Bausch Health Companies
Market Cap: CA$1.6b
Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
BHC
CA$6.02
7D
-19.3%
1Y
-49.4%
Theratechnologies
Market Cap: CA$124.1m
A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.
TH
CA$2.70
7D
14.9%
1Y
50.0%
Delivra Health Brands
Market Cap: CA$5.3m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.17
7D
0%
1Y
-51.4%
Vext Science
Market Cap: CA$33.4m
Through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States.
VEXT
CA$0.14
7D
-6.9%
1Y
-47.1%
iAnthus Capital Holdings
Market Cap: CA$67.5m
Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.
IAN
CA$0.01
7D
0%
1Y
-50.0%
Cybin
Market Cap: CA$143.0m
A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.
CYBN
CA$9.40
7D
28.1%
1Y
-51.5%
Crescita Therapeutics
Market Cap: CA$10.1m
A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.
CTX
CA$0.53
7D
-1.9%
1Y
26.2%
BioSyent
Market Cap: CA$116.7m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$10.36
7D
2.1%
1Y
19.9%
Thermo Fisher Scientific
Market Cap: CA$165.4b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
CA$16.16
7D
0.1%
1Y
-25.4%
1933 Industries
Market Cap: CA$2.5m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.005
7D
0%
1Y
-75.0%
Merck
Market Cap: CA$199.2b
Operates as a healthcare company worldwide.
MRK
CA$18.20
7D
-2.5%
1Y
n/a
Fennec Pharmaceuticals
Market Cap: CA$138.2m
Operates as a commercial stage biopharmaceutical company in the United States.
FRX
CA$7.05
7D
-7.0%
1Y
-50.4%
4Front Ventures
Market Cap: CA$9.2m
Owns and manages licensed cannabis facilities in state-licensed markets in the United States.
FFNT
CA$0.01
7D
0%
1Y
-92.3%
Covalon Technologies
Market Cap: CA$64.2m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.34
7D
0.4%
1Y
112.7%
Oncolytics Biotech
Market Cap: CA$76.1m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.
ONC
CA$0.88
7D
11.4%
1Y
-39.7%
Biocure Technology
Market Cap: CA$2.4m
Together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab.
CURE.X
CA$0.025
7D
0%
1Y
n/a
FLUENT
Market Cap: US$16.5m
Through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas.
FNT.U
US$0.055
7D
10.0%
1Y
-71.1%
Telescope Innovations
Market Cap: CA$15.6m
A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.
TELI
CA$0.29
7D
-9.4%
1Y
-19.4%
Aurora Cannabis
Market Cap: CA$325.5m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$5.93
7D
3.1%
1Y
-31.3%
High Tide
Market Cap: CA$226.6m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$2.80
7D
13.4%
1Y
-8.5%
Novartis
Market Cap: CA$163.4b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NVS
CA$20.18
7D
-4.6%
1Y
n/a
C21 Investments
Market Cap: CA$23.6m
An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.
CXXI
CA$0.20
7D
14.3%
1Y
-52.9%